key: cord-0968636-1ufrdcsa
authors: Lazzeri, Chiara; Bonizzoli, Manuela; Peris, Adriano
title: The Intriguing, Still Undercovered, Clinical Role of Echocardiography in Critically Ill Coronavirus Disease Patients
date: 2021-08-09
journal: Crit Care Med
DOI: 10.1097/ccm.0000000000005290
sha: c62f355a4e4256f04542a6b98ea8aaee78adea4d
doc_id: 968636
cord_uid: 1ufrdcsa

nan

examinations, in order to gain a more in-depth understanding of heart-lung interactions across different disease severity phases in the single patient (5); 3) an "operative" approach, in which echocardiography helps in tailoring therapy and in assessing its efficacy. For instance, the detection by echocardiography of RV dilatation and severe pulmonary hypertension may lead to initiation of inhaled nitric oxide therapy whose effects can be monitored in the single patients by serial echocardiographic examinations.

Intensive Care Unit and Regional ECMO Referral Centre, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy

Right ventricular dysfunction and its association with mortality in coronavirus disease 2019 acute respiratory distress syndrome

COVID-19 and cardiovascular disease: From basic mechanisms to clinical perspectives

The potential role and limitations of echocardiography in acute respiratory distress syndrome

Spectrum of cardiac manifestations in COVID-19: A systematic echocardiographic study

Cardiac involvment in COVID-19-related acute respiratory distress syndrome

The authors have disclosed that they do not have any potential conflicts of interest.

The authors reply: W e thank Lazzeri et al (1) for their insightful comments on our article (2) , recently published in Critical Care Medicine, and support their notion that assessment of right ventricular (RV) dysfunction (RVD) is important in the management of patients with coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS).They correctly highlight that we did not perform transthoracic echocardiography (TTE) in all our COVID-19 ICU patients, introducing a selection bias: a common flaw in retrospective (3) and prospective (4) critical care echocardiography studies. However, TTE requests were screened and protocolized: patients must have had an elevated high sensitivity (HS)-troponin I (> 14 ng/dL). As such, although one-third of these patients did not receive a TTE, they displayed a low risk of RVD and mirrored the normal RV subgroup. They had low median HS-troponin I values (12 [interquartile range (IQR), 5-14]), d-dimer values (1,264 [IQR, 510-2,230]), prevalence of renal replacement therapy (RRT) (28.1%), and 90-day mortality rate (23.6%). Nonetheless, we have not characterized RV function in all COVID-19 ICU patients, and this remains a notable limitation of the study.Second, we suspect RV dilation was associated with venous congestion due to the weak correlation between urine output and RV:left ventricular end-diastolic area, however, agree that this requires prospective validation. Although approximately half of the cohort received RRT, this was at any time point during ICU stay and not necessarily during the time of TTE. The lack of association between liver function tests and RV size does not exclude an isolated congestive hepatopathy (5) . The hepatic arterial buffer response may protect the liver at any given central venous pressure/right atrial pressure where kidney dysfunction occurs. It is unknown whether the weak correlations observed between ventilator parameters and RV fractional area change were a cause, consequence, or simply an association of the RV systolic function that was measured.